Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich area of research will see the most misconduct findings under the 2024 HHS Final Rule by the end of 2024?
Biomedical Research • 25%
Clinical Trials • 25%
Public Health Studies • 25%
Other • 25%
Official reports and statistics from the U.S. Department of Health and Human Services or relevant federal agencies
HHS Office of Research Integrity Finalizes 2024 Rule on Research Misconduct
Sep 13, 2024, 08:30 PM
The U.S. Department of Health and Human Services (HHS) has finalized the 2024 Final Rule on Public Health Service Policies on Research Misconduct. This significant update, the first major rewrite since 2005, aims to emphasize research integrity, streamline the research misconduct process, and preserve research funds. The rule aligns with the Biden-Harris Administration’s priorities of fostering scientific integrity and advancing medical science. Notably, the new regulations, finalized by the Office of Research Integrity, dropped a controversial proposal that would have allowed the publicizing of previously undisclosed misconduct findings by universities.
View original story
Complete exoneration • 25%
Partial exoneration • 25%
Complete misconduct confirmation • 25%
Inconclusive findings • 25%
Support Dr. Olson-Kennedy's decision • 25%
Criticize the withholding of results • 25%
Call for policy changes in research transparency • 25%
Other • 25%
Increased scrutiny on NIH studies • 25%
Changes in gender-affirming care policies • 25%
No significant consequence • 25%
Other consequence • 25%
Yes • 50%
No • 50%
EcoHealth Alliance • 25%
Pandemic Action Network • 25%
Center for Health Security • 25%
Other • 25%
Increased transparency • 25%
Funding restrictions • 25%
Enhanced oversight • 25%
No major changes • 25%
Study published without consequences • 25%
Study published with consequences for Dr. Olson-Kennedy • 25%
Study remains unpublished • 25%
Other outcome • 25%
Study published • 25%
NIH takes action • 25%
Congressional hearing held • 25%
No significant outcome • 25%
Revokes all grants • 33%
Revokes some grants • 34%
Takes no action • 33%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Food and Drug Administration (FDA) • 25%
National Institutes of Health (NIH) • 25%
Other • 25%
Centers for Disease Control and Prevention (CDC) • 25%